Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor α monoclonal antibody (cA2).

Autor: Perkins, Douglas J., St. Clair, E. William, Misukonis, Mary A., Weinberg, J. Brice
Zdroj: Arthritis & Rheumatism; Dec1998, Vol. 41 Issue 12, p2205-2210, 6p
Databáze: Complementary Index
Externí odkaz: